Pharma Focus Asia
KP - Choose our fully recyclable blister films

SUNOVION Launches KYNMOBI™ for the Treatment of Parkinson's Disease Off Episodes

Sunovion Pharmaceuticals Inc launched a novel drug KYNMOBI™ (apomorphine HCI) sublingual film (APL-130277) for the acute and intermittent treatment of off episodes in patients with Parkinson’s disease.

Parkinson’s disease is a chronic neurodegenerative disease, which is anticipated to affect 1.2 million Americans by 2030. It is expected that KYNMOBI is made effective in US pharmacies by September 2020.

KYNMOBI, a unique formulation of dopamine agonist apomorphine, which is supposed to be the first and only sublingual therapy acting rapidly for the treatment of OFF episodes patients associated with Parkinson’s disease. It can be used five times a day. Kynmobi, having ability to dissolve under the tongue helps people to loswer PD off symptoms.

KYNMOBI though a prescribed medicine useful for the treatment of Parkinson’s disease (PD) significantly have serious side effects such as nausea and vomiting, sleepiness or falling asleep during the day, dizziness, mouth (oral) irritation, hallucinations or psychotic behaviour, heart problems, fibrotic complications, falls and high fever.

According to the clinical studies, patients undergoing treatment with KYNMOBI medicine have resulted with significant improvements in motor symptoms at 30 minutes after dosing at week 12, with a mean reduction of 7.6 points, compared to other medicines such as placebo.

US Food and Drug Administration (FDA) has approved KYNMOBI™ (apomorphine HCI) sublingual film (APL-130277) for the acute, intermittent treatment of OFF episodes in patients with Parkinson’s disease (PD).

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024